Atlas Trials

Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT

Clinical trial NCT05614518 · COMPLETED

Trial details

NCT number
NCT05614518
Sponsor
HTA Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bone Metastases
Start date
2021-03-29
Primary completion
2022-06-02
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.